Views: 1,574 | Downloads:
32
| Responses: 0
| XML | Respond to this article | Alert & updates | Request permissions | Email to a friend |
Case ReportOpen Access
Successful Treatment of Late Onset Infection Due to Multi-Drug Resistant Acinetobacter Lwoffii in a Low Birth Weight Neonate Using Ciprofloxacin
CHOTIGEAT U 
,
KHORANA M ,
WARANAWAT N
,
KHORANA M ,
WARANAWAT N URAIWAN CHOTIGEAT,M.D.*,
MEERA KHORANA, M.D.*,
NARIS WARANAWAT,M.D.**
This report presents the case of a low birth weight neonate with multidrug-resistant
Acinetobacter Lwoffii
infection who was successfully treated with ciprotloxacin and co-trimoxazole.
Use of ciprotloxacin in pediatric populations was reviewed. The infant responded to the antibiotic
regimen with sterilized cerebrospinal fluid with no adverse effects attributable to the ciprofloxacin.
Although ciprofloxacin has been found to cause irreversible damage to cartilage in laboratory
animals, a review of the literature found that this complication rarely occurs in pediatric patients.
Ciprotloxacin has been found to be effective in the treatment of multidrug-resistant gram negative
infections in pediatric patients, including premature infants. Ciprofloxacin should be considered in
the treatment of neonatal infection caused by multidrug-resistant gram-negative organisms.
Key word
:
Acinetobacter Lwoffii,
Low Birth Weight, Ciprofloxacin
MEERA KHORANA, M.D.*,
NARIS WARANAWAT,M.D.**
This report presents the case of a low birth weight neonate with multidrug-resistant
Acinetobacter Lwoffii
infection who was successfully treated with ciprotloxacin and co-trimoxazole.
Use of ciprotloxacin in pediatric populations was reviewed. The infant responded to the antibiotic
regimen with sterilized cerebrospinal fluid with no adverse effects attributable to the ciprofloxacin.
Although ciprofloxacin has been found to cause irreversible damage to cartilage in laboratory
animals, a review of the literature found that this complication rarely occurs in pediatric patients.
Ciprotloxacin has been found to be effective in the treatment of multidrug-resistant gram negative
infections in pediatric patients, including premature infants. Ciprofloxacin should be considered in
the treatment of neonatal infection caused by multidrug-resistant gram-negative organisms.
Key word
:
Acinetobacter Lwoffii,
Low Birth Weight, Ciprofloxacin
Download:
PDF